Market Size (2017)
2017
—
Vertical: HealthcareBase Year: 201912 Sections
Market Size (2017)
2017
—
Projected (2027)
2027
—
CAGR (2017–2027)
N/A
Key Players
109+
1. Executive Summary
1.1. Market Attractiveness Analysis
1.1.1. Global Rheumatoid Arthritis Market, by Drug Type
1.1.2. Global Rheumatoid Arthritis Market, by Surgery
1.1.3. Global Rheumatoid Arthritis Market, by End User
1.1.4. Global Rheumatoid Arthritis Market, by Region
Rheumatoid Arthritis Market is a key focus area for market intelligence and strategic research.
Historical performance and future projections (2020–2030, USD Billion)
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansRheumatoid arthritis (RA) is an autoimmune disease that can cause joint pain and damage throughout your body. The joint damage that RA causes usually happens on both sides of the body. So, if a joint is affected in one of your arms or legs, the same joint in the other arm or leg will probably be affected, too.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription Plans1 Research Methodology
The research starts with the extensive procurement process of data/information and statistics from company annual reports, government websites, statistics agencies, and paid databases. This information creates a base for the study. The information also helps to define the scope and to narrow down the area for study for the market. This raw information is processed and analyzed to extract crisp data points which currently affect or are likely to affect the industry during the forecast period. After analyzing the information, a proprietary statistical tool is used for market estimation and forecast, which generates the quantitative figures/sizes of the market/sub-segments in the current scenario as well as for the forecast period.
After estimating the market sizes and estimates, the numbers are verified with industry participants and key opinion leaders. The wide network of industry participants add value to the research and verify the numbers and estimates provided in the study. At the last stage of the research process, a final report is prepared, which is then published on different websites as well as distributed through various channels. The below figure contains the different stages of the research process to produce the report.
DATA MINING
Data mining is an extensive part of our research process. It involves the procurement of market data and related information from different verified and credible sources. This step helps to obtain raw information about the product of the industry and their types, the monetary process for different end uses, the pool of market participants, and the nature of the industry and scope of the study. The data mining stage comprises both primary and secondary sources of information.
SECONDARY RESEARCH
In the secondary research process, various sources are used to identify and gather industry trends and information for the research process. We at MRFR have access to some of the most diversified and extensive paid databases, which give us the most accurate data/information on markets sizes, product, and pricing. Mentioned below is a detailed list of sources that have been used for this study. Please note that this list is not limited to the names as mentioned; we also access other data sources depending on the need.
Market Sizing & Revenue
Qualitative Information & Trends
Company Websites
· White Papers
· Magazines
· Company Websites
· Annual Reports
· Press Releases
· Investor Presentations
· Paid Databases
· Authenticated Directories
· Independent Studies
· Internal Audit Reports & Archives
· Government and Regulatory Published Material
· American Data Security Authority
· Rheumatoid Arthritis Advocacy Network.
· XXXXX
· XXXXX
Annual Reports
Investor Presentations
Authenticated Directories
Hoover’s, Factiva, Bloomberg
PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
Respondents
Data Points Received
Manufacturers
· Market Size
· Top of the Mind Key Market Players
· Direct Competitors
· Company Market Shares
· Growth Rate (%)
· Market Trends and Prominent Market Drivers
· Major Products
· Product Cost
· Commercial Availability
· Upcoming Technologies
End User
· Product Cost
· Adoption Rate & Maintenance Cost
BREAKDOWN OF PRIMARY RESPONDENTS
FORECASTING METHODS
We at MRFR follow an extensive process for arriving at market estimations, which involves the use of multiple forecasting Methods as mentioned below.
Forecasting Methods
Description
Qualitative and Quantitative Analysis
A combination of qualitative approach, i.e., primary interviews with industry experts to understand the interviewees’ opinions and judgments, more commonly known as the Delphi method, and quantitative analysis to forecast future data based on historical and current data.
Weighted Average Approach
Via this approach, future data is calculated based on the mean of the past data under the assumption that some factors affecting the market in the past will continue to have a similar impact in the future.
Drift Method
This approach is used to vary the forecast, that is increase or decrease market factor over time depending on various parameters affecting the change in the trends of the market.
Time Series Methods
Integration of several time series methods such as moving average, moving weighted average, linear prediction, and trend estimation are applied while determining the year-on-year growth rate and the compound annual growth rate of the market being studied.
Causal/Econometric Forecasting Methods
Various economic factors such as inflation rate, fiscal policies, changes in government regulations, taxes, labour costs, and interest rates are taken into consideration while determining the current market size and predicting the future market growth rate.
Judgmental Methods
This involves collection of intuitive judgment, opinions, and probability estimates from industry experts in the case of new or upcoming markets/technologies for which no prior data is available.
Regression Analysis
This type of statistical modelling is carried out for predicting and forecasting dependent and independent variables that will directly or indirectly impact the market.
Probabilistic Forecasting
This forecasting method is carried out to assign a probability to every possible outcome ranging from the least optimistic to highly optimistic, which helps in gauging the market under stable conditions.
PESTLE Analysis
Political, economic, social, technological, legal, and environmental factors are taken into consideration while deriving the fluctuations in the growth rate of the market.
Porter’s Five Forces Analysis
By understanding the supplier-side and demand-side factors, the current market scenario can be estimated, and future market scenario predicted, which aid in deriving the growth rate of the market.
RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
Understanding and penetrating the market in terms of valuation is crucial task in the process of business research. This again becomes significantly important while investing and choosing the business opportunities. In this regard, we at MRFR performs two ways market sizing approach simultaneously namely top-down and bottom-up approaches. In this step, we place different data points, numeric attributes, information and industry trends at an appropriate space to deduce the estimates & forecast values over the coming years. We use different mathematical models to estimate the market sizes of different economies and segments. Each of which is further summed up to define the total market.
We at MRFR owns a proprietary statistical tool for market estimations which helps us to comprehend market size estimates & forecasts for different markets and industries.
FIGURE 1 bottom-up and top-down approaches
MRFR Analysis Overview
BOTTOM-UP APPROACH
In the bottom-up approach, the revenue of key companies and their shares in the market is assessed to deduce the market size. More than 80% key players operating in the rheumatoid arthritis market is studied. The segmental revenue of each player is analyzed and the market size for rheumatoid arthritis market is extracted from the segmental/product revenue with the help of secondary and primary research. This extracted market size for rheumatoid arthritis market is then validated from industry experts and partner consultants. This derived market size contributes around 65 – 70% of the total global market share in terms of revenue for rheumatoid arthritis market. Using the diagnosis of data triangulation method, the overall global market size is estimated.
TOP-DOWN APPROACH
This overall market size is then used in the top-down procedure to estimate the size of the other sub-markets with the help of percentage splits of the market segments from secondary and primary research. The demand side analysis is conducted in which spent analysis for major industries in each region is studied. The end-users considered in the scope of this research study contributes around 70 % of the total in the rheumatoid arthritis market.
The countries considered in the scope of rheumatoid arthritis market are US, Canada, Mexico, the UK, Germany, France, Italy, Spain, Switzerland, Austria, Belgium, Denmark, Finland, Greece, Hungary, Italy, Luxembourg, the Netherlands, Norway, Poland, Portugal, Slovakia, Sweden, Romania, Ireland, China, Japan, Malaysia, Indonesia, the Philippines, South Korea, Singapore, India, Australia & New Zealand, South Africa, Egypt, Nigeria, Saudi Arabia, Qatar, the UAE, Bahrain, Kuwait, and Oman, Brazil, Argentina, Chile, and others. However, the number of countries vary from devices to devices and it solely depends on the product approvals in the respective countries and the commercial availability of the products.
Below figure explains the process of market estimation using independent tool employed by our analysts to get the sizing of the market.
MRFR Analysis Overview
As a part of the market engineering, the both top-down and bottom-up approaches are utilized along with data triangulation models to derive and verify the market sizes and forecast over the coming years.
DATA TRIANGULATION
After arriving at the overall market sizes, the total market is divided into several segments and sub segments. Again, market breakdown and data triangulation procedures are implemented wherever applicable, to complete the overall market engineering process and to collect the exact statistics for all segments and sub-segments. The data was triangulated by studying various factors and trends from both demand and supply sides. Along with this, the market was validated by using both top-down and bottom-up approaches.
VALIDATION
Validation is the most important stage of the report making process. Validation via an intricately designed feedback process helps us to finalize the sizing estimates and forecast for the final collation. Extensive primary research is performed to verify the information. This includes telephonic & personal interviews, mails, feedback forms, questionnaires and polling options/answers with the group of relevant people. Validation helps to duly check the authenticity of the key industry trends, market dynamics, company market share, different business models & their conclusions.
Base Year
2019
Historical Period
2017 – 2019
Forecast Period
2019 – 2027
Primary Interviews
150+
Historical data (2017–2019) and forecast period (2019–2027)
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
See plans for professionals or small and medium businesses.

Analytical insights on Rheumatoid Arthritis Market covering market dynamics, competitive landscape, and strategic outlook.
Rheumatoid Arthritis Market represents a significant market opportunity with multiple growth drivers across regions and segments.
The Rheumatoid Arthritis Market market encompasses 4 key regions and multiple market segments, with the study period spanning 2017 to 2027.
The market is segmented across multiple dimensions, with detailed breakdowns available by component, region, and application type to support strategic planning and investment decisions.
This report profiles 109 key companies operating in the Rheumatoid Arthritis Market market, covering market positioning, product portfolios, and recent developments.
Leading players include Pfizer Inc., Alcon Laboratories Inc, Eli Lilly and Company , BRISTOL-MYERS SQUIBB COMPANY, F. HOFFMANN-LA ROCHE LTD, and 104 others.
Near-term growth will likely concentrate in modular bioreactor lines and closed-system media workflows that shorten validation cycles while preserving batch traceability.
Partnerships between CDMOs and instrumentation vendors should accelerate standard datasets for comparability across sites, improving forecasting models used in capacity planning.
Longer horizon, organoid and microphysiological adoption may reshape segment mix; teams that invest early in assay interoperability and cloud QC hooks are better positioned to capture upside without fragmenting their analytics stack.
Profiles of 109 companies operating in the Rheumatoid Arthritis Market market, including revenue, employee count, and market positioning where available.
Showing 109 of 109 companies
Pfizer Inc.
Company Headquarters: New York, US Founded: 1849 Workforce: ~83,000 Company Working: Pfizer Inc. (Pfizer) is a leading research-based biopharmaceutical company that applies science and resources to provide innovative treatments that extend and significantly improve lives. Pfizer discovers, develops, manufactures, and sells healthcare products worldwide. It operates through two segments: Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). It also provides sterile injectable pharmaceuticals, biosimilars, active pharmaceutical ingredients (APIs), and contract manufacturing services. Pfizer sells its products through wholesalers, retailers, hospitals, clinics, government agencies, and pharmacies. It has major manufacturing facilities in India, China, Japan, Ireland, Italy, Belgium, Germany, Singapore, and the US. Furthermore, the company supplies its products in North America, South America, Asia-Pacific, Australia, Europe, Africa, and the Middle East.
BRISTOL-MYERS SQUIBB COMPANY
Company Headquarters: New York, US Founded: 1887 Workforce: ~28,000 Company Working: Bristol-Myers Squibb Company merged with Squibb in 1989. Bristol-Myers Squibb Company is a leading pharmaceutical company committed to develop and deliver innovative biopharmaceutical products to help patients fight diseases globally. It mainly focuses on six core therapeutic areas such as oncology, musculoskeletal, virology, cardiovascular, metabolomics, and immunology.
AstraZeneca
Company Headquarters: Cambridge, UK Founded: 1999 Workforce: 83,100 Company Working: AstraZeneca is a leading biopharmaceutical company. It focuses on developing and commercializing prescribed medicines. It has three main therapy areas, namely, cardiovascular, and metabolic disease (CVMD), oncology, and respiratory. It is also active in areas such as neuroscience autoimmunity and infection. It has more than 164 projects in its pipeline, nine new molecular entities in its late-stage pipeline, and one new molecular entity approval in the last quarter of 2019. Its product portfolio includes medications in the field of oncology, cardiovascular, renal & metabolism, and respiratory diseases, among others. Geographically the company operates in more than 100 countries by offering its healthcare products to millions of people across the globe.
Novartis AG.
Company Headquarters: Basel, Switzerland Founded: 1996 Workforce: 1, 26,000 Company Working: Novartis AG was established in 1996 through a merger of Ciba-Geigy and Sandoz. Novartis AG and its predecessor companies have a rich history of developing innovative new products that trace back to more than 250 years. The company focuses on the development and marketing of new products that contribute to human progress through advances in science and health. It provides ophthalmology, neuroscience, immunology, hepatology, dermatology, respiratory, cardio-metabolic, and established medicine products.
Eli Lilly and Company
Company Headquarter: Indianapolis, Indiana, US Founded: 1876 Workforce: 42,066 Company Working: Eli Lilly and Company is an American global pharmaceutical company. The company also has offices in Puerto Rico and 17 other countries. Its products are sold in approximately 125 countries. The company is listed on the New York Stock Exchange, and its shares had been a component of the S&P 500 Index since 1971. Lilly was the first company to mass-produce penicillin, the Salk polio vaccine, and insulin. Its achievements include being one of the first pharmaceutical companies to produce human insulin using recombinant DNA including Humulin, Humalog, and the first approved biosimilar insulin product in the US, Basaglar. Lilly is also the world's largest manufacturer and distributor of psychiatric medications including Prozac (Fluoxetine), Dolophine (Methadone), Cymbalta (Duloxetine), and Zyprexa (olanzapine). Some of the top competitors of Eli Lilly and Company are Pfizer Inc., GlaxoSmithKline PLC, Biogen, Sanofi, and Johnson and Johnson.
F. HOFFMANN-LA ROCHE LTD
Incorporated in 1896 and headquarters in Basel, Switzerland; F. Hoffmann-La Roche AG is the world's biggest biotech organization, with genuinely differentiated solutions in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is additionally the world pioneer in vitro diagnostics and tissue-based cancer diagnostics, and a leader in diabetes management. The consolidated qualities of pharmaceuticals and diagnostics under one rooftop have made Roche the pioneer in personalized healthcare. The products offered by the company helps in tapping in the world’s two third of all the diseases which are either not treated effectively or not treated at all. The company offers various products in the Pharmaceutical, Diagnostics and research industry. Geographically the company operates in North America, Europe, South America, Africa, Asia and Oceania. As of 2015 F. Hoffmann-La Roche AG had a head count of 91,700 + employees world wide Roche Strategy – a methodology that intends to fit the right treatment to every patient in the most ideal way that could be available dedicated on developing innovative diagnostic tests and medicines which will help their patients and the world.
Powering the world's best teams.
From next-gen startups to established enterprises.
Trusted by forward-thinking businesses
for data-driven intelligence
Rheumatoid Arthritis Market